| P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy MG Khalafalla, LT Woods, JM Camden, AA Khan, KH Limesand, MJ Petris, ... Journal of Biological Chemistry 292 (40), 16626-16637, 2017 | 85 | 2017 |
| Increased expression of TGF-β signaling components in a mouse model of fibrosis induced by submandibular gland duct ligation LT Woods, JM Camden, FG El-Sayed, MG Khalafalla, MJ Petris, L Erb, ... PLoS One 10 (5), e0123641, 2015 | 65 | 2015 |
| Purinergic signaling in Alzheimer’s disease L Erb, LT Woods, MG Khalafalla, GA Weisman Brain research bulletin 151, 25-37, 2019 | 29 | 2019 |
| P2 receptors as therapeutic targets in the salivary gland: from physiology to dysfunction MG Khalafalla, LT Woods, KJ Jasmer, KM Forti, JM Camden, JL Jensen, ... Frontiers in Pharmacology 11, 222, 2020 | 25 | 2020 |
| P2Y2R deletion ameliorates sialadenitis in IL‐14α‐transgenic mice LT Woods, JM Camden, MG Khalafalla, MJ Petris, L Erb, JL Ambrus Jr, ... Oral diseases 24 (5), 761-771, 2018 | 18 | 2018 |
| P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells FG El-Sayed, JM Camden, LT Woods, MG Khalafalla, MJ Petris, L Erb, ... American Journal of Physiology-Cell Physiology 307 (1), C83-C96, 2014 | 18 | 2014 |
| Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8+ T cell antitumor immunity TND Pham, C Spaulding, MA Shields, AE Metropulos, DN Shah, ... JCI insight 7 (9), 2022 | 6 | 2022 |
| P2Y purinergic signaling in prostate cancer: Emerging insights into pathophysiology and therapy MG Khalafalla, HN Tran, FG Khalafalla Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (3), 188732, 2022 | 5 | 2022 |
| Hepatic Deletion of X-Box Binding Protein 1 in FXR Null mice leads to enhanced liver injury X Liu, M Khalafalla, C Chung, Y Gindin, S Hubchak, B LeCuyer, ... Journal of lipid research 63 (11), 2022 | 3 | 2022 |
| INOSITOL-REQUIRING ENZYME 1a/X-BOX BINDING PROTEIN 1 (IRE1a/XBP1) PATHWAY REGULATES HEPATIC BILE ACID METABOLISM M Khalafalla, A Benintende, X Liu, A Kriegermeier, B LeCuyer, RM Green HEPATOLOGY 78, S1794-S1794, 2023 | | 2023 |
| THE X-BOX BINDING PROTEIN 1 (XBP1s) AGONIST IXA4 REGULATES HEPATIC BILE ACID METABOLISM A Benintende, M Khalafalla, M Naibryf, X Liu, A Kriegermeier, E Saez, ... HEPATOLOGY 78, S1797-S1797, 2023 | | 2023 |
| Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin MA Shields, C Spaulding, AE Metropulos, MG Khalafalla, TND Pham, ... Cell reports 38 (9), 2022 | | 2022 |
| Abstract PO-094: Gα13 loss in KPC mouse model promotes well-differentiated pancreatic tumors that are susceptible to mTOR inhibition MA Shields, C Spaulding, MG Khalafalla, TND Pham, HG Munshi Cancer Research 81 (22_Supplement), PO-094-PO-094, 2021 | | 2021 |
| Abstract PO-049: Inhibiting MNK kinases promotes macrophage immunosuppressive phenotype to limit anti-tumor immunity TND Pham, C Spaulding, MA Shields, MG Khalafalla, DR Principe, ... Cancer Research 81 (22_Supplement), PO-049-PO-049, 2021 | | 2021 |
| G alpha 13 loss in KPC mouse model promotes well-differentiated pancreatic tumors that are susceptible to mTOR inhibition. MA Shields, C Spaulding, MG Khalafalla, TND Pham, HG Munshi CANCER RESEARCH 81 (22), 63-63, 2021 | | 2021 |
| THE ROLE OF X-BOX BINDING PROTEIN 1 IN FARNESOID X RECEPTOR NULL MICE X Liu, M Khalafalla, C Chung, Y Gindin, SC Hubchak, B LeCuyer, ... HEPATOLOGY 74, 295A-296A, 2021 | | 2021 |
| Gα13 loss promotes tumor progression in the KPC transgenic mouse model of advanced pancreatic cancer MA Shields, C Spaulding, MG Khalafalla, TND Pham, HG Munshi bioRxiv, 2021.03. 15.435488, 2021 | | 2021 |
| Abstract PO-060: Gna13 delays disease progression in mouse models of pancreatitis and pancreatic cancer MA Shields, C Spaulding, MG Khalafalla, TDN Pham, HG Munshi Cancer Research 80 (22_Supplement), PO-060-PO-060, 2020 | | 2020 |
| Loss of Gna13 Worsens Disease Progression in Mouse Models of Pancreatitis and Pancreatic Cancer MA Shields, C Spaulding, MG Khalafalla, TDN Pham, HG Munshi PANCREAS 49 (10), 1429-1430, 2020 | | 2020 |
| P2X7 and P2Y2 receptors as therapeutic targets in Sjogren's syndrome mouse models AL Martin, MG Khalafalla, KJ Jasmer-McDonald, LT Woods, JM Camden, ... CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 36 (3), S282-S283, 2018 | | 2018 |
Gary A. WeismanProfessor of Biochemistry, University of Missouri, Bond Life Science CenterVerified email at missouri.edu
